Phase 2 Study of the Safety and Efficacy of Vicriviroc, a...

The Journal of Infectious Diseases 2007 / 07 Vol. 196; Iss. 2

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV‐1–Infected, Treatment‐Experienced Patients: AIDS Clinical Trials Group 5211

Gulick, Roy M., Su, Zhaohui, Flexner, Charles, Hughes, Michael D., Skolnik, Paul R., Wilkin, Timothy J., Gross, Robert, Krambrink, Amy, Coakley, Eoin, Greaves, Wayne L., Zolopa, Andrew, Reichman, Rich
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
196
Language:
english
Journal:
The Journal of Infectious Diseases
DOI:
10.1086/518797
Date:
July, 2007
File:
PDF, 311 KB
english, 2007
Conversion to is in progress
Conversion to is failed